[ad_1]
Melbourne, Australia, May 28, 2019 / PRNewswire / – A new revolutionary non-invasive embryo screening test will reduce the number of miscarriages and the time it takes for one in six Australian couples affected by infertility to have a healthy life.
In a world first scientific, From Australia The most prominent scientists in the field of fertility have developed a DNA screening test in embryos that is non-invasive and will be available to a larger number of patients at lower cost.
The existing biopsy technique – the standard worldwide – can only be used on the most potent embryos, which means that many embryos are never tested for DNA. Embryos that do not contain the correct amount of chromosome pairs often result in miscarriage or a child born with a genetic defect. This risk increases rapidly when a woman gets older. Genetic tests can identify these embryos before they are transferred to the uterus.
This is a significant step forward in the generalization of genetic testing for IVF.
Medical Director of the Monash IVF Group Luk Rombauts said that it was an exciting development for patients, especially those at higher risk of miscarriage or pregnancy failure.
"It has long been the holy grail for genetic testing because many embryos were not powerful enough for a biopsy," says Professor Rombauts.
"The current practice of pre-implantation genetic screening of embryos has resulted in improved pregnancy rates, but we felt that there was a better way of screening that could be applied to more embryos." ."
"The oldest patients who would benefit the most would be absent because most or all of their embryos would not be suitable for embryo biopsy.Thanks to this new advance, these embryos can be examined, which increases their chances of a successful pregnancy. "
The new test – developed by the Monash IVF group – is non-invasive. It allows clinicians to screen for embryos that were not considered robust enough for biopsy, but can still lead to a healthy baby.
Professor Rombauts stated that the main benefit of the new test is that it allows more embryos to be delivered to patients who really need it, at a lower cost and without the need for biopsy. Invasive surgical embryo.
Scientists in the Monash IVF group have discovered that, during the growth and division of embryonic cells, they secrete DNA into the culture medium in which they develop. This sample can then be tested for abnormalities in the chromosomes.
"Without IVF, many Australian families simply would not exist," says the professor Michelle Lane, who led the development of the test.
"But for some, the trip can be long and emotional."
"This is a fantastic result for research in reproduction in Australia who is set to help more people in Australia to become parents for the first time."
"The Monash IVF group created From Australia First pregnancy by FIV and make genetic testing more accessible to many Australians through a test that will help IVF patients get a healthy baby's birth faster. "
the UA$ 495 test is available from today. It has been validated over two years via two clinical trials. Learn more about this test on www.monashivf.com.
About the Monash IVF Group
Monash IVF Group is a leading provider of fertility treatment, imaging and diagnostic services for women Australia and Malaysia. The group continues to invest significant amounts in research and plays a leading role in the development of badisted reproductive technologies. The Monash IVF group has had many firsts in Australia and around the world since the early work of our pioneers, who obtained the first IVF pregnancy in the world in 1973. Today, a Monash IVF baby is born every two hours. and a half. Monash IVF Group – Helping to bring the world to life
SOURCE Monash IVF
Related Links
http://www.monashivf.com
Source link
